Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Finance
  • Published:

Quantifying the dream: Valuation approaches in biotechnology

Nature Biotechnology volume 16, pages 55–56 (1998)Cite this article

Abstract

Bioentrepreneurs should have a keen grasp of how Wall Street determines value in order to prepare their company for public markets.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. managing director and head, health care group, investment banking division, Paine Webber Inc., 1285 Avenue of the Americas, New York, 10019, NY

    Stelios Papadopoulos

Authors
  1. Stelios Papadopoulos
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Papadopoulos, S. Quantifying the dream: Valuation approaches in biotechnology. Nat Biotechnol 16 (Suppl 1), 55–56 (1998). https://doi.org/10.1038/5431

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/5431

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing